Tap any paragraph to write a margin note. Your notes collect in the Desk below the text and file under cases with @. The side-by-side margin rail opens on a larger screen.

Code · REGISTER · 2023-06-01 · Agency for Healthcare Research and Quality (AHRQ), HHS · Rules and Regulations

Rules and Regulations. Notice

310 words·~1 min read·/register/2023/06/01/2023-11656

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

BILLING CODE 6730-02-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Healthcare Research and Quality Notice of Meeting AGENCY: Agency for Healthcare Research and Quality (AHRQ), HHS. ACTION: Notice. SUMMARY: The Agency for Healthcare Research and Quality
(AHRQ)announces a Special Emphasis Panel
(SEP)meeting on “Diagnostic Safety in Ambulatory Care.” This SEP meeting will be closed to the public. DATES: July 26-27, 2023. ADDRESSES: Agency for Healthcare Research and Quality (Video Assisted Review), 5600 Fishers Lane, Rockville, Maryland 20857. FOR FURTHER INFORMATION CONTACT: Jenny Griffith, Committee Management Officer, Office of Extramural Research, Education and Priority Populations, Agency for Healthcare Research and Quality, (AHRQ), 5600 Fishers Lane, Rockville, Maryland 20857, Telephone:
(301)427-1557. SUPPLEMENTARY INFORMATION: A Special Emphasis Panel is a group of experts in fields related to health care research who are invited by AHRQ, and agree to be available, to conduct on an as needed basis, scientific reviews of applications for AHRQ support. Individual members of the Panel do not attend regularly scheduled meetings and do not serve for fixed terms or a long period of time. Rather, they are asked to participate in a particular review meeting which require their type of expertise. The SEP meeting referenced above will be closed to the public in accordance with the provisions set forth in 5 U.S.C. 1009(d), 5 U.S.C. 552b(c)(4), and 5 U.S.C. 552b(c)(6). Grant applications for “Diagnostic Safety in Ambulatory Care” are to be reviewed and discussed at this meeting. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Agenda items for this meeting are subject to change as priorities dictate. Dated: May 26, 2023. Marquita Cullom, Associate Director. [FR Doc. 2023-11656 Filed 5-31-23; 8:45 am]
Connections3 off-index
3 references not yet in our index
  • 5 USC 1009(d)
  • 5 USC 552b(c)(4)
  • 5 USC 552b(c)(6)
Citation graph
cites case law
Rules and Regulations
Notice
Cite5 USC 1009(d)
Cite5 USC 552b(c)(4)
Cite5 USC 552b(c)(6)
Cites 3Cited by 0 across 0 sources
★   the supreme law of the land   ★
Don't Tread on Me
E Pluribus Unum — out of many, one

"If you don't know your rights, you don't have any."

Marginalia · a citizen's law index
A research desk, not legal advice. Always read the cited source before relying on a summary.
Questions or an issue? support@self-law.org
disclaimerMarginalia is a research index, not a law firm. Nothing on this site is legal, tax, or financial advice and no attorney–client relationship is formed by using it. Statutes, regulations, and case law change; summaries, search results, AI output, and member posts may be incomplete, out of date, or wrong. Any interpretation drawn from material on this site should be validated by a licensed attorney in your jurisdiction before you act on it.